tert-butylhydroperoxide has been researched along with Insulin Resistance in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Álvarez, C; Escrivá, F; Fernández-Millán, E; Goya, L; Lizárraga-Mollinedo, E; Martín, MA; Ramos, S | 1 |
1 other study(ies) available for tert-butylhydroperoxide and Insulin Resistance
Article | Year |
---|---|
Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation.
Topics: Animals; Antioxidants; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Extracellular Signal-Regulated MAP Kinases; Glucagon-Like Peptide 1; Glucose; Glutathione; Glutathione Reductase; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Isoquinolines; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reactive Oxygen Species; Sulfonamides; tert-Butylhydroperoxide; Uncoupling Protein 2 | 2016 |